XML 26 R10.htm IDEA: XBRL DOCUMENT v3.19.2
Basic and Diluted Earnings Per Share
12 Months Ended
May 31, 2019
Basic and Diluted Earnings Per Share [Abstract]  
Basic and Diluted Earnings Per Share

Note C — Basic and Diluted Earnings Per Share

Basic and diluted earnings per share were calculated as follows:







 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

Year ended May 31,



 

 

 

 

2018

 

2017

In millions, except per share amounts

 

2019

 

As Adjusted(1)

 

As Adjusted(1)

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Net income

 

$

1,034.4 

 

$

994.1 

 

$

826.3 

Weighted-average common shares outstanding

 

 

359.2 

 

 

359.0 

 

 

359.8 

Basic earnings per share

 

$

2.88 

 

$

2.77 

 

$

2.30 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Net income

 

$

1,034.4 

 

$

994.1 

 

$

826.3 

Weighted-average common shares outstanding

 

 

359.2 

 

 

359.0 

 

 

359.8 

Dilutive effect of common share equivalents

 

 

2.6 

 

 

2.5 

 

 

2.8 

Weighted-average common shares outstanding, assuming dilution

 

 

361.8 

 

 

361.5 

 

 

362.6 

Diluted earnings per share

 

$

2.86 

 

$

2.75 

 

$

2.28 

Weighted-average anti-dilutive common share equivalents

 

 

0.4 

 

 

0.7 

 

 

0.7 



(1) Amounts have been adjusted to reflect the adoption of ASC Topic 606.



Weighted-average common share equivalents that had an anti-dilutive impact are excluded from the computation of diluted earnings per share.

The Company maintained a program to repurchase up to $350.0 million of the Company's common stock, with authorization that expired on May 31, 2019.  During fiscal 2019 and fiscal 2018,  the Company repurchased 0.7 million shares for $56.9 million and 2.5 million shares for $143.1 million, respectively, under this repurchase program.  All shares repurchased were retired.  In May 2019, the Company announced that its Board approved a program to repurchase up to $400.0 million of the Company’s common stock, with authorization running from June 1, 2019 through May 31, 2022.  The purpose of these programs is to manage common stock dilution.